Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Nirsevimab: History, Applications & Research

Nirsevimab, sold under the brand name Beyfortus, is a human recombinant monoclonal antibody with activity against respiratory syncytial virus (RSV). It is a respiratory syncytial virus (RSV) F protein‑directed fusion inhibitor that is designed to bind to the fusion protein on the surface of the RSV virus.

Language: English [EN]
Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.
100%
More settings
100% 100% 100% 100% 100%

Nirsevimab topic overview

The analysis highlights History, Applications and Research as prominent areas in the source structure around Nirsevimab.

Related topics
23
Source areas
5
Connected nodes
28
Extracted relationships
69
Concept neighborhoods
15
Bridge connections
28

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

History · 9 topics
Overview · 7 topics
Research · 3 topics
Medical uses · 2 topics
Pharmacology · 2 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

AHFS/Drugs.com
Micromedex Detailed Consumer Information
ATC code
J06BD08 (WHO)
CAS Number
1989556-22-0
ChEMBL
ChEMBL4297575
DrugBank
DB16258
Formula
C6494H10060N1708O2050S46

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

Medical uses

Pharmacology

History

Research

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How Nirsevimab connects Entity context

The extracted context around Nirsevimab shows recurring relationship patterns in the source. For example, Nirsevimab → April, AstraZeneca AB, Beyfortus, Canada, Committee, EMA's, European Medicines Agency, European Union, Human Use, In November, In September, It, July, Medicinal Products, RSV, The, United Kingdom, United States Another extracted example is Nirsevimab → Committee, European Medicines Agency, Human Use, II/III, Medicinal Products, RSV, Synagis, The. Use these groups to spot repeated connection types before inspecting the individual relationships.

Nirsevimab

Top relations

related to Legal status · 18
Nirsevimab → April, AstraZeneca AB, Beyfortus, Canada, Committee, EMA's, European Medicines Agency, European Union, Human Use, In November, In September, It, July, Medicinal Products, RSV, The, United Kingdom, United States
related to history · 8
Nirsevimab → Committee, European Medicines Agency, Human Use, II/III, Medicinal Products, RSV, Synagis, The
related to Medical uses · 8
Nirsevimab → Alternatively, CDC, European Union, In, October, RSV, RSVpreF, United States
related to Research · 6
Nirsevimab → April, As, Initial, LRTI, RSV, The MELODY
Legal status · 5
Nirsevimab → AU: S4 (Prescription only), CA: ℞-only / Schedule D, EU: Rx-only, UK: POM (Prescription only), US: ℞-only
related to Mechanism of action · 3
Nirsevimab → Fc, It, RSV
Other names · 2
Nirsevimab → MEDI8897, nirsevimab-alip
has effect · 2
Nirsevimab → NCT02878330, No
AHFS/Drugs.com · 1
Nirsevimab → Micromedex Detailed Consumer Information
ATC code · 1
Nirsevimab → J06BD08 (WHO)

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

rsv infants respiratory preterm 2023 trial safety disease placebo lrti april virus lower tract season randomized ma use syncytial beyfortus

Nirsevimab relationships Subject–Predicate–Object triples

TTTA extracted 69 structured relationships around Nirsevimab. Examples in this analysis include Nirsevimab → AHFS/Drugs.com → Micromedex Detailed Consumer Information and Nirsevimab → ATC code → J06BD08 (WHO). The table shows each extracted connection, where it came from and its confidence.

SubjectPredicateObjectConfidenceSrc
NirsevimabAHFS/Drugs.comMicromedex Detailed Consumer Information1.00infobox
NirsevimabATC codeJ06BD08 (WHO)1.00infobox
NirsevimabCAS Number1989556-22-01.00infobox
NirsevimabChEMBLChEMBL42975751.00infobox
NirsevimabDrugBankDB162581.00infobox
NirsevimabFormulaC6494H10060N1708O2050S461.00infobox
NirsevimabKEGGD113801.00infobox
NirsevimabLegal statusAU: S4 (Prescription only)1.00infobox
NirsevimabLegal statusCA: ℞-only / Schedule D1.00infobox
NirsevimabLegal statusUK: POM (Prescription only)1.00infobox
NirsevimabLegal statusUS: ℞-only1.00infobox
NirsevimabLegal statusEU: Rx-only1.00infobox
NirsevimabLicense dataUS DailyMed: Nirsevimab1.00infobox
NirsevimabMolar mass146336.58 g·mol−11.00infobox
NirsevimabOther namesMEDI88971.00infobox
NirsevimabOther namesnirsevimab-alip1.00infobox
NirsevimabPregnancy categoryAU: B21.00infobox
NirsevimabPubChem SID3845853581.00infobox
NirsevimabRoutes of administrationIntramuscular1.00infobox
NirsevimabSourceHuman1.00infobox
NirsevimabTargetF protein of RSV1.00infobox
NirsevimabTrade namesBeyfortus1.00infobox
NirsevimabTypeWhole antibody1.00infobox
NirsevimabUNIIVRN8S9CW5V1.00infobox

Related concept clusters Concept neighborhoods

The concept neighborhoods around Nirsevimab bring nearby vocabulary together. In this analysis, examples include Rsv, Infants and Safety. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

  • Nirsevimab
    • Rsv
    • Infants
    • Safety
    • Respiratory
    • Preterm
    • Placebo
    • Randomized
    • Double-blind
    • Efficacy
    • Term
    • Lrti
    • Trial
  • nirsevimab
    • Rsv
    • Infants
    • Safety
    • Respiratory
    • Preterm
    • Placebo
    • Randomized
    • Double-blind
    • Efficacy
    • Term
    • Lrti
    • Trial
  • monoclonal antibody
    • Syncytial
    • Virus
    • Phase
    • Study
    • April
    • Respiratory
    • Human
    • Safety
    • Beyfortus
    • Placebo-controlled
    • Double-blind
    • Efficacy
  • respiratory syncytial virus
    • Syncytial
    • Virus
    • Lower
    • Tract
    • Antibody
    • Protein
    • Rsv
    • Respiratory
    • Infants
    • Disease
    • Phase
    • Term
  • rsv fusion (f) protein
    • Virus
    • Season
    • Infants
    • Syncytial
    • Ma
    • Disease
    • Lower
    • Lrti
    • Tract
    • First
    • Use
    • Administration
  • committee for medicinal products for human use
    • European
    • Antibody
    • First
    • Syncytial
    • Human
    • Medical
    • United
    • Use
    • Virus
    • Respiratory
    • Disease
    • Lower
  • european medicines agency
    • Use
    • Human
    • Medical
    • United
    • First
    • Disease
    • Lower
    • Season
    • Tract
    • Infants
    • Nirsevimab
    • Protein
  • congenital heart disease
    • Lower
    • Tract
    • Respiratory
    • Rsv
    • Season
    • Infants
    • Trial
    • Human
    • Age
    • Born
    • European
    • First

Connections between topic areas Semantic bridges

For Nirsevimab, one of the stronger structural bridges in this analysis connects Nirsevimab with History. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3
Nirsevimab — History · splits 19 ⟂ 10
Nirsevimab — Overview · splits 21 ⟂ 8
Nirsevimab — Research · splits 25 ⟂ 4
Nirsevimab — Medical uses · splits 26 ⟂ 3
Nirsevimab — Pharmacology · splits 26 ⟂ 3

Map overview Semantic statistics

Nirsevimab

Nodes29
Edges28
Triples69
Avg. degree1.93
Density0.068966
Components1

Source & methodology

TTTA analyzes the structure around Nirsevimab to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Applications & Research, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Nirsevimab · EN edition · Analysis: TopicsToTalkAbout

For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.